Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein

David P Smith, Deborah Tew, Andrew F Hill, Stephen Paul Bottomley, Colin Louis Masters, Kevin Jeffrey Barnham, Roberto Cappai

Research output: Contribution to journalArticleResearchpeer-review

56 Citations (Scopus)


The alpha-synuclein (alpha-syn) protein is clearly implicated in Parkinson s disease (PD). Mutations or triplication of the alpha-syn gene leads to early onset PD, possibly by accelerating alpha-syn oligomerization. alpha-syn interacts with lipids, and this membrane binding activity may relate to its toxic activity. To understand how the alpha-syn aggregation state affects its lipid binding activity we used surface plasmon resonance to study the interaction of wild-type and mutant alpha-syn with a charged phospholipid membrane, as a function of its aggregation state. Apparent dissociation constants for alpha-syn indicated that an intermediate species, present during the lag phase of amyloid formation, binds with an increased affinity to the membrane surface. Formation of this species was dependent upon the rate of fibril formation. Fluorescence anisotropy studies indicate that only upon the formation of amyloid material can alpha-syn perturb the acyl-chain region of the lipid bilayer. Circular dichroism spectroscopy showed that upon aging, both wild-type and mutant alpha-syn lose their ability to form lipid-bound alpha-helical species once they become fibrillar. These results indicate that alpha-syn forms a high affinity lipid binding intermediate species during fibril formation. Oligomeric alpha-syn is known to be toxic, and it is feasible that the high affinity binding species described here may correspond to a toxic species involved in PD.
Original languageEnglish
Pages (from-to)1425 - 1434
Number of pages10
Issue number5
Publication statusPublished - 2008

Cite this